Rheumatoid Arthritis Drug Actemra Linked to Heart Complications, Death

The FDA has received reports of more than 1,100 patient deaths likely linked to the rheumatoid arthritis (RA) medicine Actemra. Unfortunately, consumers were not warned regarding the medication’s potentially deadly side effects. Manufactured by Roche/Genentech, Actemra has been prescribed to more than 760,000 patients and has generated sales of $1.7 billion globally. It works by... Read More

Metal Hip Replacements May Cause Metallosis, Other Injuries

An MDL, or Multi-District Litigation, for the Stryker LFIT V40 hip replacement has been formed in U.S. District Court of Massachusetts, consolidating cases nationwide into a single court system. In August 2016, Stryker issued a voluntary Class 2 Recall for this particular hip implant. Stryker cited multiple complaints involving taper lock failure. Patients have complained... Read More

Alert: Class I Recall Issued for Spinal Fusion Device

The FDA has announced Zimmer Biomet’s Class 1 Recall of the SpF PLUS-Mini and SpF XL IIb Implantable Spinal Fusion Stimulators. The reason behind the recall is a risk for chronic infections, paralysis, long-term hospitalization due to additional surgical procedures, and death. The devices, used during spinal fusion surgery, were determined to contain higher-than-allowed levels... Read More

Rule Aiming to Protect Elderly Residents is Reversed

For many years, nursing homes have required residents and their families to agree to a mandatory binding arbitration, waiving their right to sue facilities for abusive or improper care and instead requiring them to settle any issues outside of court. Last fall, the Obama Administration aimed to reverse the common practice of barring residents from... Read More
1 2 3 17